Profound Medical Corp. - Common Shares (PROF)

CUSIP: 74319B502

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Shares
Shares outstanding
29,881,634
Total 13F shares
7,634,234
Share change
-91,787
Total reported value
$98,724,050
Put/Call ratio
56%
Price per share
$13.01
Number of holders
29
Value change
-$1,129,044
Number of buys
13
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74319B502?
CUSIP 74319B502 identifies PROF - Profound Medical Corp. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2023

As of 30 Jun 2023, Profound Medical Corp. - Common Shares (PROF) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,634,234 shares. The largest 10 holders included GAGNON SECURITIES LLC, FIL Ltd, LETKO, BROSSEAU & ASSOCIATES INC, Timelo Investment Management Inc., Gagnon Advisors, LLC, Raymond James Financial Services Advisors, Inc., ROYCE & ASSOCIATES LP, Royal Bank of Canada, BANK OF AMERICA CORP /DE/, and NATIONAL BANK OF CANADA /FI/. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.